AI is transforming drug discovery – but success requires more than algorithms. It demands IND-ready data, expert scientific guidance, and seamless integration across computational and experimental workflows.
At Eurofins Discovery, we combine decades of curated, standardized data with wet lab excellence to refine AI predictions. We are more than a CRO – we are your modality-agnostic strategic partner, helping you accelerate smarter decisions, reduce development risk, and bridge in silico and in vitro approaches with integrated solutions.
Human Insight Driving the AI-Wet Lab Loop
From Code to Compound
Streamline your drug discovery workflow and accelerate development:
- Computational design with wet lab validation for AI predictions
- Active learning feedback loops to refine predictive models
- Rapid hypothesis-driven drug discovery for hit-to-lead acceleration
- De novo design of novel molecules
- Reduced timelines with lower risk and improved ROI
What We Deliver
- Data-rich outputs optimized for machine learning pipelines
- Validated assay/product portfolio including 3,000+ GPCRs assays, 500+ kinases assays, 400+ ion channels, cytokines, and 200+ checkpoint inhibitors with strong SOPs and strict QC standards
- Custom assay development for novel targets from protein engineering to biophysical and structural biology
- Safety, ADME, and toxicity profiling
- Medicinal, Synthetic and Analytical Chemistry with short DMTA cycle
- Confidentiality and IP protection through structural safeguards
Proprietary Data Advantage
Eurofins Discovery offers decades of curated data generated under standardized conditions with strict quality control, enabling accurate modeling for selectivity, ADME, and toxicity. This allows for direct inter-assay comparison of datasets for AI-model construction and more reliable predictions.
Q&A:
- What is AI-driven drug discovery?
AI-driven drug discovery combines computational modeling, machine learning, and wet lab validation to accelerate hit-to-lead programs and improve decision-making in the developments of new drugs. - Why must AI-powered drug design be tested in the wet lab?
AI predictions require experimental validation to ensure accuracy and reliability. Eurofins Discovery provides wet lab testing, IND-ready data, and integrated computational workflows to refine AI models and reduce development risk. - How does a Eurofins Discovery support AI-powered drug design?
Eurofins Discovery is a CRO that provides IND-ready data, curated datasets, wet lab validation alongside integrated computational and experimental workflows to refine AI predictions and reduce development risk.
